Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,250.00
0.00 (0.00%)
At close: Sep 19, 2025

Sinil Pharmaceutical Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
11,47514,30113,64112,1576,6797,544
Upgrade
Depreciation & Amortization
5,6615,6075,3614,4324,5364,432
Upgrade
Loss (Gain) From Sale of Assets
0.09-3.72641.55-221.3-14-13.42
Upgrade
Asset Writedown & Restructuring Costs
-31-31792.08-14.5-97.5
Upgrade
Loss (Gain) From Sale of Investments
26.8126.81532.61373.44-115.4811.37
Upgrade
Provision & Write-off of Bad Debts
-13.5797.59446.86409.12160.62472.81
Upgrade
Other Operating Activities
1,2563,161-408.832,9032,102565.25
Upgrade
Change in Accounts Receivable
1,936855.221,095-3,247161.49147.62
Upgrade
Change in Inventory
-3,252-369.61-2,304-3,487236.85-1,865
Upgrade
Change in Accounts Payable
-97.84-113.72-1,2711,8401,210-288.05
Upgrade
Change in Other Net Operating Assets
-1,700-1,541-2,587-1,563-3,779152.7
Upgrade
Operating Cash Flow
15,26122,68915,15413,68811,16311,062
Upgrade
Operating Cash Flow Growth
-40.84%49.72%10.72%22.61%0.92%-10.11%
Upgrade
Capital Expenditures
-7,653-10,362-13,604-10,351-3,343-8,801
Upgrade
Sale of Property, Plant & Equipment
18.174.92122.76316.6145.6828.82
Upgrade
Sale (Purchase) of Intangibles
-173.84-94.64-57-27.5-285.65-101.55
Upgrade
Investment in Securities
-6,443-13,2682,510-4,880-3,103177.8
Upgrade
Other Investing Activities
148.5176.53-291.662.27-9529.95
Upgrade
Investing Cash Flow
-14,103-23,473-11,319-14,880-6,665-8,609
Upgrade
Short-Term Debt Issued
--22,578---
Upgrade
Total Debt Issued
--22,578---
Upgrade
Short-Term Debt Repaid
---22,578---
Upgrade
Long-Term Debt Repaid
--147.23-154.09-133.75-127.98-122.81
Upgrade
Total Debt Repaid
-150.8-147.23-22,732-133.75-127.98-122.81
Upgrade
Net Debt Issued (Repaid)
-150.8-147.23-154.09-133.75-127.98-122.81
Upgrade
Repurchase of Common Stock
---73.39-104.49-168.43-6.26
Upgrade
Dividends Paid
-2,196-1,965-1,112-1,081-1,051-1,126
Upgrade
Other Financing Activities
62-2492--0-
Upgrade
Financing Cash Flow
-2,285-2,136-1,248-1,319-1,347-1,255
Upgrade
Foreign Exchange Rate Adjustments
-80.0944.83-11.37114.9425.44-9.82
Upgrade
Miscellaneous Cash Flow Adjustments
---0---
Upgrade
Net Cash Flow
-1,207-2,8762,576-2,3963,1761,188
Upgrade
Free Cash Flow
7,60812,3271,5513,3367,8202,261
Upgrade
Free Cash Flow Growth
-52.56%694.85%-53.52%-57.34%245.93%-12.24%
Upgrade
Free Cash Flow Margin
9.40%13.78%1.74%4.17%12.66%3.68%
Upgrade
Free Cash Flow Per Share
658.151066.39134.13299.94695.63200.87
Upgrade
Cash Interest Paid
23.826.9726.136.059.7213.24
Upgrade
Cash Income Tax Paid
2,498468.263,081772.841,1131,721
Upgrade
Levered Free Cash Flow
3,5638,588-2,857148.738,141-2,130
Upgrade
Unlevered Free Cash Flow
3,5788,605-2,840152.528,147-2,122
Upgrade
Change in Working Capital
-3,114-1,169-5,067-6,457-2,170-1,853
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.